Creative Biolabs provides a specialized platform for the detailed analysis of epithelial-mesenchymal plasticity. What we provide is a multi-layered evaluation of cellular state transitions, moving beyond binary classifications to capture stable intermediate states. Our clients gain a deep understanding of how their lead candidates modulate cellular motility, survival, and stem-like properties, enabling more informed decisions during the early stages of drug development.
Cancer stem cells represent a small, highly plastic subpopulation of cells within research models that drive growth and therapeutic evasion. Growing evidence from peer-reviewed literature suggests that targeting these cells is essential for understanding tumor biology. Our service utilizes these scientific insights to provide a testing environment that accounts for cellular plasticity, metabolic flexibility, and microenvironmental shielding, ensuring that drug sensitivity results translate effectively within the discovery pipeline.
Fig.1 Schematic representation of cellular changes and main molecular events during EMT and the reverse MET. 1
We develop bespoke experimental architectures tailored to specific cancer types, utilizing diverse research-grade models to replicate unique tumor microenvironments and biological variables.
Seamlessly transition projects from high-throughput 2D monolayer screens to physiologically relevant 3D spheroid models that better simulate complex tissue invasion dynamics.
We utilize diverse induction protocols, including specialized chemical cocktails and hypoxia modeling, to trigger plasticity programs through various biologically relevant signaling pathways.
Our integrative approach spans from assessing initial chromatin accessibility and transcriptional bivalency to conducting final functional assays for survival and metastatic fitness.
Creative Biolabs stands as a global leader in cellular dynamics research, offering high-resolution insights into the complex molecular programs governing EMT.
Our specialized platform is built upon years of biological expertise, allowing researchers to detect subtle and stable "hybrid" cellular states.
Our proprietary AI-morphology engine provides improved sensitivity for detecting early-state transitions that traditional protein staining methods often fail to capture.
We move beyond standard binary assays to provide a nuanced understanding of cellular plasticity, helping clients avoid common pitfalls in drug screening.
Reach out to our experts to secure a detailed project proposal and pricing structure for your upcoming assessment.
We utilize multi-parametric algorithms combining adhesion marker density with AI-driven morphology. Hybrid states are accurately identified through the simultaneous retention of epithelial junctions and mesenchymal migration.
Yes, our specialized assessment effectively supports research in wound healing and tissue regeneration, providing deep insights into plasticity programs across various non-malignant biological models and pathways.
We quantify basement membrane degradation and extracellular matrix restructuring through advanced assays monitoring matrix metalloproteinase activity and structural breakdown kinetics.
Learn More →We analyze metabolic flux and bioenergetic shifts, providing critical data on glucose uptake, mitochondrial respiration, and glycolytic dependencies in heterogeneous tumor environments.
Learn More →Creative Biolabs offers a sophisticated EMT/Cell Plasticity program assessment service, bridging the gap between biological theory and modern drug discovery. By combining AI-driven diagnostics with functional validation, we empower your team to overcome resistance and study metastasis.
For detailed project discussions or to receive a service specification, please reach out to our team.
Reference